Crossmark

In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes

Crossref DOI link: https://doi.org/10.1007/s00277-020-03908-8

Published Online: 2020-01-18

Published Print: 2020-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Opie, Jessica http://orcid.org/0000-0002-1408-2604
Antel, Katherine

Koller, Ania

Novitzky, Nicolas
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (D43-TW010345, D43-TW010543)
License Information

Text and Data Mining valid from 2020-01-18

Version of Record valid from 2020-01-18
More Information

Article History

Received: 1 October 2019

Accepted: 13 January 2020

First Online: 18 January 2020

Change Date: 19 February 2020

Change Type: Correction

Change Details: The article “In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes”.

Compliance with ethical standards

: The Human Research Ethics Committee at the University of Cape Town approved the study. All procedures followed were in accordance with institutional and national ethical standards and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was waived in view of the retrospective nature of the study. Confidentiality and anonymity of patient data was maintained throughout.

: The authors declare that they have no conflict of interest.

Updates are available Correction dated 2020-02-19

Click to view Correction: https://doi.org/10.1007/s00277-020-03964-0